Non-Small Cell Lung Cancer Therapeutics Market to Reach US$ 64.92 Billion by 2033 | Datam Intelligence
Non-Small Cell Lung Cancer Therapeutics market projected to hit US$ 64.92B by 2033, driven by targeted therapy, immunotherapy, and rising lung cancer prevalence LOS ANGELES, CA, UNITED STATES, November 12, 2025 /EINPresswire.com/ -- Global Non- …